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Introduction
Semaphorins are a large family of secreted, transmembrane, 
or glycosylphosphatidylinositol-linked proteins defined by a 
semaphorin domain (Kolodkin et al., 1993; Luo et al., 1993). 
They exert most of their effects through a family of trans-
membrane receptors, called plexins (Winberg et al., 1998; 
Tamagnone et al., 1999). Semaphorins and plexins have 
been shown to play crucial roles in a multitude of biological 
contexts, including the nervous, immune, bone, and cardio-
vascular systems, as well as in cancer (Takamatsu and Kuma-
nogoh, 2012; Gu and Giraudo, 2013; Messina and Giacobini, 
2013; Worzfeld and Offermanns, 2014). In various cell types, 
semaphorin–plexin signaling regulates key cellular functions, 
particularly cytoskeletal dynamics and cell migration (Kruger 
et al., 2005; Casazza et al., 2007).
On the basis of phylogenetic tree analysis and the pres-
ence of additional protein motifs, mammalian semaphorins 
are grouped into five classes. Class 3 semaphorins are secreted 
molecules, the class 7 semaphorin, semaphorin 7A (Sema7A), 
is glycosylphosphatidylinositol linked to the membrane, and 
semaphorins of classes 4, 5, and 6 represent transmembrane 
proteins (Worzfeld and Offermanns, 2014). The extracellular 
portion of class 4 semaphorins can be proteolytically cleaved, 
allowing them to also act as soluble ligands (Wang et al., 2001; 
Hemming et al., 2009; Fong et al., 2011; Armendáriz et al., 
2012; Nakatsuji et al., 2012). Importantly, all class 4 sema-
phorins possess short (between 57 and 149 amino acids) cyto-
plasmic domains, which, in the case of Sema4B, 4C, 4F, and 4G, 
have been shown to interact with intracellular proteins, includ-
ing PSD-95 (Inagaki et al., 2001; Burkhardt et al., 2005), SEM 
CAP-1 and -2 (GIPC1/2; Wang et al., 1999), Norbin (Ohoka 
et al., 2001), and CLCP1 (Nagai et al., 2007). Plexins, in turn, 
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are classified into four subfamiles, A–D, according to structural 
characteristics (Tamagnone et al., 1999).
Although it is well established that the binding of sema-
phorins to plexins triggers several plexin-mediated signaling 
pathways (Hota and Buck, 2012; Jongbloets and Pasterkamp, 
2014), it remains largely unclear whether transmembrane sema-
phorins can also serve as receptors, rather than ligands, and 
signal in a reverse manner (Gurrapu and Tamagnone, 2016). 
Several studies in the developing nervous system of Drosophila 
melanogaster provide evidence that Sema1a, a transmembrane 
semaphorin found in invertebrates, transduces signals evoked 
by binding of plexins, which depend on the intracellular domain 
of Sema1a (Godenschwege et al., 2002; Cafferty et al., 2006; 
Komiyama et al., 2007; Yu et al., 2010). In vertebrates, a recep-
tor function has been assigned to Sema6B, which controls axon 
guidance in the developing chick nervous system (Andermatt 
et al., 2014). Moreover, it has been suggested that murine Plex-
in-B2 regulates epidermal γδ T cell functions through Sema4D 
(Witherden et al., 2012). However, the underlying molecular 
mechanisms remain elusive.
In this study, we show that Sema4A serves as a receptor 
for Plexin-B1 and mediates Plexin-B1–induced reverse signal-
ing. Mechanistically, we uncover Scrib as a critical mediator 
of Sema4A downstream signaling in cancer and dendritic cells 
(DCs). Sema4A interacts with Scrib in a Plexin-B1–dependent 
manner, resulting in decreased membrane localization of Scrib 
and a loss of the interaction between Scrib and the guanine nu-
cleotide exchange factor βPIX, thus negatively regulating the 
activity of the small GTPases Cdc42 and Rac1. Furthermore, 
we provide evidence that this Sema4A–Scrib–βPIX signaling 
pathway is critical to promote Plexin-B1–induced migration and 
invasion of various cancer cells as well as the migration of DCs.
Results
Plexin-B1 induces migration and invasion of 
cancer cells via Sema4A reverse signaling
Class 4 semaphorins and B-family plexins have been linked to 
the regulation of the cytoskeleton and cell migration (Driessens 
et al., 2001; Swiercz et al., 2008). To test whether class 4 sema-
phorins can act as receptors, rather than ligands, in the context 
of cancer cell migration, we purified an extracellular portion of 
Plexin-B1 containing semaphorins and a plexin-semaphorin-in-
tegrin (PSI) domain (ecPlxnB1). In accordance with published 
data, ecPlxnB1 contained all structural elements required for 
the binding to the class 4 semaphorin, Sema4D (Fig 1 a; Janssen 
et al., 2010). In a panel of cancer cell lines of different origin, 
comprising pancreatic (MIA PaCa-2, AsPc, T3M4, and CFP 
AC), skin (A431), brain (SHSY-5Y), cervical (HeLa), breast 
(MDA-MB-231), and lung (Calu-3) cancer cell lines, we ob-
served that ecPlxnB1 increased the migratory behavior of some, 
but not all, cancer cell lines (Figs. 1 b and S1 a). We hypothe-
sized that this was caused by a class 4 semaphorin, which acts 
as an ecPlxnB1 receptor and is present on responsive cell lines 
but absent from unresponsive cell lines. We therefore system-
atically analyzed the expression of class 4 semaphorins in the 
cancer cell lines and found that only Sema4A fulfilled these 
criteria (Figs. 1 c and S1 b). Of note, Sema4A has been shown 
to bind to Plexin-B1 (Yukawa et al., 2010). To test whether the 
ecPlxnB1-induced effects on cancer cell migration are medi-
ated by Sema4A, we silenced Sema4A expression by siRNA 
in ecPlxnB1-responsive cell lines (Fig. S1, c and d). Indeed, 
knockdown of Sema4A, but not of other class 4 semaphorins, 
suppressed ecPlxnB1-induced migratory behavior (Fig. 1 d). To 
test whether the intracellular portion of Sema4A is required to 
transduce signals triggered by the binding of ecPlxnB1 to Se-
ma4A, we silenced endogenous Sema4A by siRNA, followed 
by overexpression of siRNA-resistant wild-type Sema4A or of 
siRNA-resistant mutant Sema4A lacking the intracellular por-
tion (Sema4AΔC). Both wild-type and mutant Sema4A were 
expressed at comparable levels (Fig. S1 e), reached the plasma 
membrane, and bound ecPlxnB1 in a similar manner (Fig. S1, 
f and g). Whereas expression of wild-type Sema4A rendered 
cells fully responsive to the promigratory effects of ecPlxnB1, 
expression of Sema4AΔC did not (Figs. 1 e and S1 h). More-
over, we engineered MIA PaCa-2 cells to stably express shRNA 
directed against endogenous Sema4A as well as cDNAs en-
coding shRNA-resistant versions of either wild-type or mutant 
Sema4A (Sema4AΔC; Fig. S1 i). Although cells expressing 
wild-type Sema4A showed an increase in invasive behavior 
in response to ecPlxnB1, cells expressing Sema4AΔC lacked 
the proinvasive response to ecPlxnB1 (Fig. 1 f). Of note, cells 
expressing wild-type or mutant Sema4A (Sema4AΔC) showed 
similar rates of proliferation (Fig. S1 j). Moreover, we observed 
that AsPc cells, which do not express endogenous Sema4A and 
do not normally respond to ecPlxnB1, become migratory in re-
sponse to ecPlxnB1 upon expression of wild-type Sema4A, but 
not of the Sema4AΔC mutant (Fig. S1 k). Collectively, these 
data indicate that Sema4A can act as a receptor for Plexin-B1 
and signals through its intracellular portion to promote cancer 
cell migration and invasion.
Sema4A reverse signaling in DCs induces 
directional migration toward Plexin-B1
To test for a wider biological significance of Plexin-B1–
Sema4A reverse signaling, we extended our analyses to another 
biological system. Because Sema4A was reported to be highly 
expressed by bone marrow–derived DCs (BMDCs) and splenic 
DCs (Kumanogoh et al., 2002), we tested whether Sema4A 
could serve as a receptor for Plexin-B1 also on these cells. In-
deed, we observed that primary BMDCs exhibited chemotaxis 
toward ecPlxnB1 (Fig. 2 a). Similarly, ecPlxnB1 also attracted 
primary splenic DCs (Fig. S2 a) in transwell migration and 3D 
chemotaxis assays (Figs. 2 b and S2 b). To examine whether 
these ecPlxnB1-induced effects on DC migration are mediated 
by Sema4A reverse signaling, we used Sema4A-deficient mice 
(Figs. 2 d and S2 c; Xia et al., 2015) from which we isolated 
BMDCs. Indeed, we found that BMDCs lacking Sema4A 
showed no directed migration toward ecPlxnB1 (Fig.  2  c). 
This was not caused by a general defect in cell motility, as Se-
ma4A-deficient BMDCs reacted normally to the promigratory 
chemokine CCL19 (Fig. 2 c) and exhibited similar motility as 
wild-type BMDCs (Fig. S2 e). Reexpression of wild-type Se-
ma4A, but not of Sema4AΔC, rescued the ability of DCs to re-
spond to ecPlxnB1 (Fig. 2 d). These results show that Sema4A 
serves as a receptor for Plexin-B1 on DCs to promote chemo-
taxis via reverse signaling.
The migration of DCs toward lymphatic 
vessels requires Sema4A and Plexin-B1
To assess the physiological relevance of Sema4A reverse signal-
ing in DCs, we analyzed the migratory behavior of DCs toward 
lymphatic vessels of explanted ear sheets of mice. Compared 
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Figure 1. Plexin-B1 promotes cancer cell migration and invasion through its receptor Sema4A. (a) A purified His-Myc–tagged extracellular portion of Plex-
in-B1 (ecPlxnB1; amino acids 20–534 of human Plexin-B1) and His-tagged Sema4D were mixed in equimolar concentrations and incubated in the presence 
of anti-Myc antibodies. Protein complexes were then precipitated using protein A/G agarose. Proteins were immunoblotted and visualized using an anti-His 
antibody. IB, immunoblotting; IP, immunoprecipitation. (b) MIA PaCa-2, AsPc, T3M4, CFP AC, A431, or MDA-MB-231 cells were seeded onto 96-transwell 
migration plates in the absence or presence of 150 nM ecPlxnB1, and cell migration was analyzed as described in Materials and methods. Shown are mean 
values ± SD from duplicates of three independent experiments (total n = 6 per condition). CTRL, control. (c) Expression analysis of class 4 semaphorins in cancer 
cell lines by RT-PCR. (d) MIA PaCa-2 cells were transfected with control or siRNA directed against Sema4A, B, C, D, F, or G (as indicated). Cell migration in the 
absence or presence of 150 nM ecPlxnB1 was tested using a transwell system as described in Materials and methods. Shown are mean values ± SD of three 
independent experiments (total n = 5 per condition). ns, not significant. (e) MIA PaCa-2 cells were transfected with control or Sema4A siRNA. After 48 h, cells 
were transfected with cDNA encoding siRNA-resistant wild-type or mutant Sema4A lacking the intracellular part. Cell migration was tested using a transwell 
system. Shown are mean values ± SD from duplicates of three independent experiments (total n = 6 per condition). (f) MIA PaCa-2 cells were stably transfected 
with either control shRNA or shRNA against Sema4A. Where indicated, cells were additionally transfected with cDNA encoding shRNA-resistant wild-type 
Sema4A (WT) or shRNA-resistant Sema4A lacking its intracellular portion (∆C). Cells were seeded onto Matrigel-coated filters (total n = 6 per condition). 
Invaded cells were stained and counted. Error bars represent means ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 2. Plexin-B1–Sema4A reverse signaling regulates DC migration in vitro. (a–d) The migratory behavior of mature BMDCs (a, c, and d) or splenic 
DCs (b) exposed to control buffer (CTRL), to a gradient of ecPlxnB1, or to a gradient of CCL19 was analyzed as described in Materials and methods. Gra-
dients are indicated by a red triangle at the right side of the depicted plots. Each line represents a track of an individual cell. Cell tracks with an endpoint 
in the top half of the plot (i.e., on the side of the lower agonist concentration) are labeled in black, and cell tracks with an endpoint in the bottom half of 
the plot (i.e., on the side of the higher agonist concentration) are labeled in red. (c) Mature BMDCs generated from wild-type (WT) or Sema4A knockout 
(KO) mice were examined. ns, not significant. (d) BMDCs isolated from Sema4A knockout mice were infected with lentiviruses carrying full-length wild-
type Sema4A (V5-Sema4A FL) or Sema4A lacking the intracellular part (V5-Sema4AΔC). After maturation, cell migration was analyzed. FMIy, y-forward 
migration index. Total numbers of analyzed cells are CTRL, n = 57 and ecPlxnB1, n = 51 (a); CTRL, n = 32 and ecPlxnB1, n = 60 (b); WT/CTRL, n = 47; 
WT/ecPlxnB1, n = 38; WT/CCL19, n = 43; KO/CTRL, n = 36; KO/ecPlxnB1, n = 30; and KO/CCL19, n = 40 (c); and FL/CTRL, n = 26; FL/ecPlxnB1, n = 
34; FL/CCL19, n = 25; ΔC/CTRL, n = 26; ΔC/ecPlxnB1, n = 33; and ΔC/CCL19, n = 31 (d). Error bars represent means ± SD. *, P < 0.05; **, P < 0.01.
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with wild-type BMDCs, Sema4A-deficient BMDCs were im-
paired in their ability to migrate toward ear lymphatic vessels 
(Figs. 3 a and S3 a). Given that lymphatic endothelial cells play 
an important role in guiding DCs to lymphatic vessels (Heuzé et 
al., 2013; Platt and Randolph, 2013), they seemed to be a likely 
source of Plexin-B1 to attract DCs via activation of Sema4A re-
verse signaling. Indeed, Plexin-B1 is not only expressed in arte-
rial cells and human microvascular endothelial cells (HMV ECs; 
Basile et al., 2005; Giusti et al., 2006), but also in lymphatic 
endothelial cells (Fig. S3 b; Nelson et al., 2007). Moreover, an 
extracellular portion of Plexin-B1 of ∼70 kD in size is released 
from lymphatic endothelial cells (HMV EC-dLyAd; Fig. S3, c 
and d). Fully consistent with a role of Plexin-B1 as a ligand 
for Sema4A on DCs, BMDCs were impaired in their ability to 
migrate toward ear lymphatic vessels of Plexin-B1–deficient 
mice (Fig.  3 b). The knockout of Plexin-B1 in ear lymphatic 
vessels led to a slightly stronger impairment of BMDC migra-
tion than the knockout of Sema4A in BMDCs (Fig. 3, a and b). 
Therefore, although Sema4A accounted for a large fraction of 
the Plexin-B1–induced promigratory effect on BMDCs, other 
transmembrane semaphorins could serve as additional recep-
tors for Plexin-B1 on BMDCs. Indeed, Sema4D is coexpressed 
with Sema4A in BMDCs (Fig. S3, e and f). To examine the 
role of Sema4A reverse signaling in BMDC migration in more 
detail, we used a live-cell imaging approach (Video  1). This 
analysis showed that the migration speed and distance of Se-
ma4A-deficient BMDCs were lower than of wild-type BMDCs 
(Fig. 3, c–e). However, these differences were rather subtle and 
therefore unlikely to fully explain the observed impairment of 
Sema4A-deficient BMDCs to migrate toward lymphatic ves-
sels. Against the background of our in vitro experiments, which 
had shown a defective chemotactic behavior of Sema4A-defi-
cient BMDCs toward a Plexin-B1 gradient, we hypothesized 
that Sema4A-deficient BMDCs might display an altered di-
rectionality of migration toward Plexin-B1–expressing lym-
phatic vessels. For individual cells, we therefore determined the 
angle between the shortest possible distance to the lymphatic 
vessel and the observed actual vector of migration (Fig. 3  f). 
Indeed, we found that Sema4A-deficient BMDCs migrated at 
higher angles (i.e., less directly toward lymphatic vessels) than 
wild-type BMDCs (Fig. 3 f).
Identification of downstream 
effectors of Sema4A
Our data show that the intracellular portion of Sema4A is 
crucial to mediate reverse signaling. To further elucidate the 
signaling pathway downstream of activated Sema4A, our 
goal was to identify proteins that interact with its intracellu-
lar portion. We therefore expressed the recombinant intracel-
lular portion of Sema4A, incubated it with lysates of various 
cell lines (MIA PaCa-2, SK-OV-3, HEK293T, and CaD2), and, 
after precipitation, identified binding partners by mass spec-
trometry (Fig. 4 a). An analogous approach was taken for all 
other class 4 semaphorins (not depicted). As Plexin-B1–Se-
ma4A reverse signaling promotes cell migration, we reasoned 
that the functional relevance of Sema4A-interacting proteins 
could be assessed by testing their involvement in this promigra-
tory effect. We therefore silenced the expression of individual 
candidates by siRNA in MIA PaCa-2 cells and tested for the 
impact on ecPlxnB1-induced cell migration. The knockdown 
of several Sema4A-interacting proteins severely impaired the 
ability of cells to respond to ecPlxnB1, with the knockdown of 
Scrib having the strongest effect (Fig. 4 b). The critical role of 
Scrib in ecPlxnB1-induced cell migration was confirmed with 
an independent siRNA in both MIA PaCa-2 cells (Fig. S4, a 
and b) and in T3M4 cells (Fig. S4, c and d). To verify the in-
teraction between Scrib and Sema4A, we performed coimmu-
noprecipitation experiments in HEK293T cells. Although we 
could not detect an interaction of the intracellular portion of 
Sema4A with Scrib in the absence of ecPlxnB1, we observed 
binding in the presence of ecPlxnB1 (Fig. 4 c). These results 
were confirmed in MIA PaCa-2, T3M4, and CaD2 cells, which 
express endogenous Scrib (Fig. 4 d). Furthermore, in primary 
BMDCs, application of ecPlxnB1 resulted in the formation of 
a Sema4A–Scrib complex (Fig. 4 e). In addition to Scrib, our 
GST-pulldown approach (Fig.  4  a) had identified seven other 
potential Sema4A-interacting proteins, the siRNA-mediated 
knockdown of four of which showed an inhibition of the ecPlx-
nB1-induced promigratory effect (Fig. 4 b). However, in coim-
munoprecipitation experiments in the absence and presence of 
ecPlxnB1, we could not detect an interaction between Sema4A 
and these proteins (encoded by the snx27, tln1, prkd2, or ran 
genes; not depicted). To map the interaction sites between 
Scrib and Sema4A, we cloned several deletion mutants of Scrib 
(Fig. 4 f) and tested for their ability to interact with the intra-
cellular portion of Sema4A in HEK293T cells. This analysis 
showed that Scrib binds to the intracellular portion of Sema4A 
via its C-terminal part (amino acids 1224 and 1630), a region to 
which no functions have been assigned so far (Fig. 4 g).
Sema4A reverse signaling regulates the 
activity of small GTPases
Scrib has been shown to control the activity of the small 
GTPases Rac1 and Cdc42, which are crucially involved in the 
regulation of cell migration (Audebert et al., 2004; Osmani 
et al., 2006; Momboisse et al., 2009; Spiering and Hodgson, 
2011). We therefore tested whether Plexin-B1 regulates Cdc42 
and/or Rac1 activity through Sema4A and Scrib. We found that 
application of ecPlxnB1 to MIA PaCa-2 or T3M4 cells resulted 
in a reduction of Cdc42 and Rac1 activity (Fig. 5, a and b; and 
Fig. S5, a–c). Furthermore, exposure to ecPlxnB1 also lowered 
the activity of Cdc42 in BMDCs (Fig. 5 c). The inhibition of 
Cdc42 and Rac1 activity by ecPlxnB1 was dependent on Se-
ma4A, as shRNA-mediated knockdown of Sema4A in MIA 
PaCa-2 cells (Figs. 5 a and S5, a and b) or knockout of Sema4A 
in BMDCs (Fig. 5 c) rendered cells unresponsive to ecPlxnB1. 
The loss of the ecPlxnB1-induced effect on Cdc42 and Rac1 
activity in MIA PaCa-2 cells with shRNA-mediated knock-
down of Sema4A could be fully rescued by overexpression of 
shRNA-resistant wild-type Sema4A, but not overexpression of 
Sema4AΔC (Figs. 5 a and S5, a and b). Of note, the effect of 
ecPlxnB1 on the activity of small GTPases was restricted to 
Cdc42 and Rac1, as activities of the closely related small GT-
Pases RhoA, RhoB, or RhoC were not influenced (Fig. S5, d–f). 
To gain further insight into the ecPlxnB1-induced Sema4A-me-
diated modulation of Cdc42 and Rac1 activity, we tried to 
visualize Cdc42 and Rac1 activity with spatial and temporal 
resolution. Along these lines, we used Förster resonance energy 
transfer (FRET) assays using Cdc42 and Rac1 biosensors (Mar-
tin et al., 2016) in different experimental setups. In a first series 
of measurements, we applied ecPlxnB1 to the medium so that 
the plasma membrane of each analyzed cell got uniformly ex-
posed to ecPlxnB1. In full accordance with the pulldown assays, 
this led to a reduction of Cdc42 and Rac1 activity in a Sema4A- 
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dependent manner (Fig. 5, d and e; and Fig. S5 g). However, in 
our in vitro and ex vivo migration assays, and likely also under 
physiological conditions in vivo, the concentration of Plexin-B1 
is not uniform around the cell, but rather it forms a gradient. 
In an attempt to mimic a physiologically relevant situation, we 
therefore exposed cells to a polarized ecPlxnB1 stimulus. We 
observed that Cdc42 activity decreased at the site of ecPlxnB1 
application (Fig.  5  f), indicating that a gradient of ecPlxnB1 
translates into polarized modulation of Cdc42 activity. To test 
whether ecPlxnB1 regulates Cdc42 and Rac1 activity through 
Sema4A/Scrib, we aimed at specifically interfering with the Se-
ma4A–Scrib interaction. We hypothesized that overexpression 
of the C-terminal portion of Scrib (amino acids 1224–1630), 
which interacts with Sema4A (see Identification of downstream 
effectors of Sema4A), could compete for the interaction of wild-
type Scrib with Sema4A, thereby acting as a dominant-negative 
form. Indeed, we found that overexpression of the C-terminal 
portion of Scrib decreased the ecPlxnB1-induced interaction of 
Sema4A and Scrib and blocked ecPlxnB1-induced Rac1 deacti-
vation (Figs. 5 g and S5 h).
Plexin-B1 regulates Scrib localization 
through Sema4A
Scrib localization critically influences Scrib activity (Navarro et 
al., 2005; Osmani et al., 2006). We therefore tested whether Se-
ma4A could regulate the distribution of Scrib within cells. Al-
though Scrib localized to the plasma membrane of T3M4 cells 
in the absence of ecPlxnB1 (Fig. 6 a), application of ecPlxnB1 
induced the internalization of Scrib in a time-dependent man-
ner (Fig.  6, a and b, top left panel). This effect of ecPlxnB1 
was dependent on Sema4A, as shRNA-mediated knockdown 
of Sema4A (Fig. S5 i) restored the plasma membrane localiza-
tion of Scrib (Fig. 6 b). Expression of shRNA-resistant wild-
type Sema4A in Sema4A shRNA–expressing cells rendered 
the cells responsive to ecPlxnB1 again, whereas expression of 
shRNA-resistant mutant Sema4AΔC did not (Fig. 6 b). These 
Figure 3. Plexin-B1 and Sema4A regulate DC migration ex vivo. (a) Mature BMDCs generated from wild-type (WT) and Sema4A knockout mice (Se-
ma4A KO) were fluorescently labeled (WT, yellow; Sema4A KO, green), mixed 1:1, and used for the ex vivo migration assay (right). After 1.5 h, BMDCs 
associated with lymphatic vessels were quantified (left). Examples of wild-type (white arrows) and Sema4A-knockout (blue arrows) BMDCs not associated 
with lymphatic vessels are marked. (b) Mature BMDCs generated from wild-type mice were allowed to migrate into ear sheets of wild-type or Plexin-B1 
knockout mice for 1.5 h (right). BMDCs associated with lymphatic vessels were quantified (left). Examples of BMDCs not associated with lymphatic vessels 
are marked with white arrows. (c) Mature BMDCs generated from wild-type and Sema4A knockout mice were fluorescently labeled (WT, green; Sema4A 
KO, blue), mixed 1:1, and used for live-cell imaging (different time points shown). (d and e) Quantification of migration speed (d) and distance (e) of 
BMDCs with the indicated genotypes. (f) Analysis of the migration angle of BMDCs relative to the lymphatic vessel. Dashed white lines represent the shortest 
possible distance to lymphatic vessels. Red horizontal lines indicate means ± SEM. Colored arrows represent vectors of BMDC migration. Bar graphs in a 
and b show mean values ± SD from three independent experiments. Graphs in d–f are based on six independent experiments. Total numbers of analyzed 
cells are WT, n = 1,993 and Sema4A KO, n = 1,785 (a); WT ear, n = 1,786 and Plexin-B1 KO ear, n = 1,560 (b); WT, n = 172 and Sema4A KO, 
n = 239 (d and e); and WT, n = 157 and Sema4A KO, n = 164 (f). Error bars represent means ± SD (a and b) or SEM (d–f). *, P < 0.05; ***, P < 0.001.
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results indicate that Plexin-B1 regulates Scrib localization 
through Sema4A reverse signaling. Given that Scrib has been 
shown to be involved in the regulation of protein trafficking (La-
huna et al., 2005), we next asked whether Scrib, in turn, controls 
the localization of Sema4A. After application of ecPlxnB1, we 
detected a significant decrease of Sema4A surface expression 
(Fig. 6 c). This effect was abrogated by siRNA-mediated knock-
down of Scrib (Fig. 6 c).
Plexin-B1–Sema4A reverse signaling 
interferes with the interaction of 
Scrib and βPIX
Scrib has been shown to regulate Rac1 and Cdc42 activity 
through its interaction with the Rac1/Cdc42 guanine nucle-
otide exchange factor (GEF) βPIX (Audebert et al., 2004; 
Osmani et al., 2006; Nola et al., 2008). Therefore, we tested 
whether Plexin-B1, through its receptor Sema4A, could impact 
the Scrib–βPIX complex. In HEK293T cells, application of 
ecPlxnB1 reduced the binding of Scrib to βPIX (Fig. 7 a). To 
test for the functional significance of the Scrib–βPIX interaction 
in the Plexin-B1–Sema4A reverse signaling pathway, we per-
formed siRNA-mediated knockdown of βPIX in MIA PaCa-2 
cells. We observed that βPIX silencing abolished the effects of 
ecPlxnB1 on cell migration (Fig. 7 b). In THP1 cells differen-
tiated to DCs, which endogenously express Sema4A (Fig. S4 
e), ecPlxnB1 led to the deactivation of Cdc42 and increased 
cell migration in a Scrib- and βPIX-dependent manner (Fig. 7, 
c and d; and Fig. S4 f). Cells with siRNA-mediated knockdown 
of Scrib or βPIX were still partially responsive to the known 
promigratory factors FBS or CCL19 (Fig. 7, b and d; Berges 
et al., 2005; Marsland et al., 2005), indicating a specific role 
for Scrib and βPIX in the Plexin-B1–Sema4A reverse signaling 
Figure 4. Scrib mediates reverse signaling of Sema4A. (a) Workflow for the identification of proteins interacting with the intracellular portion (IC) of class 
4 semaphorins by mass spectrometry. For details, see Materials and methods. (b) MIA PaCa-2 cells transfected with the indicated siRNAs were examined 
in transwell migration assays in the absence or presence of 150 nM ecPlxnB1. The ecPlxnB1-induced effect on cells transfected with siRNA directed against 
the gene of interest is normalized to the ecPlxnB1-induced effect on cells transfected with control siRNA (percentage). Genes encoding for proteins identi-
fied as potential Sema4A-interacting partners by the GST pulldown approach are colored in red. Error bars represent the mean ± SD. (c) HEK293T cells 
were transfected with plasmids encoding HA-tagged Scrib (HA-Scrib) alone or together with V5-tagged Sema4A (V5-Sema4A). After serum starvation and 
stimulation with or without ecPlxnB1, cells were lysed, and proteins were immunoprecipitated (IP) using anti-V5 or anti-HA antibodies coupled to protein 
A/G sepharose. Bound proteins were then separated and visualized using anti-HA or anti-V5 antibodies (as indicated). (d) MIA PaCa-2, CaD2, or T3M4 
cells were serum starved and stimulated as indicated. Sema4A or Scrib were immunoprecipitated using the respective antibodies (IP). Protein complexes 
were visualized by Western blotting (immunblotting [IB]). (e) Mature BMDCs were generated from wild-type mice (WT) or Sema4A knockout mice (Sema4A 
KO). Cells were stimulated with or without 150 nM ecPlxnB1 and lysed, and protein complexes were immunoprecipitated using anti Scrib antibodies. 
Proteins were then immunoblotted using specific antibodies as indicated. (f) Schematic representation of GFP-tagged Scrib constructs used in this study. 
(g) HEK293T cells were transfected with V5-tagged Sema4A and constructs encoding GFP-tagged wild-type or deletion mutants of Scrib (as indicated). 
Protein complexes were immunoprecipitated in the presence of 150 nM ecPlxnB1 using anti-V5 antibody and visualized using the indicated antibodies. 
Error bars represent means ± SD. *, P < 0.05.
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pathway. Moreover, blocking the Sema4A–Scrib interaction by 
overexpressing the C-terminal portion of Scrib (amino acids 
1224–1630) in MIA PaCa-2 cells inhibited the promigratory 
effect of ecPlxnB1 (Fig. 7 e).
Discussion
Class 4 semaphorins are a widely expressed group of transmem-
brane proteins (Yazdani and Terman, 2006; Gu and Giraudo, 
2013; Kang and Kumanogoh, 2013). Although the role and im-
portance of these semaphorins as ligands have been well es-
tablished (Gu and Giraudo, 2013; Roney et al., 2013; Worzfeld 
and Offermanns, 2014), their potential function as receptors to 
mediate cellular effects through reverse signaling is poorly un-
derstood (Battistini and Tamagnone, 2016). In this study, we 
systematically characterized a potential receptor function of 
a particular semaphorin, Sema4A, and analyzed cell behavior 
and changes in signaling pathways induced by a soluble extra-
cellular portion of Plexin-B1. Indeed, we found that Plexin-B1 
increases the migration of cancer and of DCs through reverse 
signaling mediated by Sema4A.
Plexin-B1 is known to bind to both Sema4A and Sema4D 
(Granziero et al., 2003; Yukawa et al., 2010). However, our 
data show that Plexin-B1 can trigger cellular effects through 
reverse signaling of Sema4A, but not of Sema4D. This may be 
explained by the existence of additional, not yet identified core-
ceptors or by semaphorin-specific downstream mediators.
In this study, we used a soluble extracellular portion of 
Plexin-B1 to activate Sema4A-mediated reverse signaling. In 
contrast to full-length plexins, the role and function of their 
secreted versions remain largely unexplored. In the case of 
Plexin-B1, the secreted ectodomain may be the result of al-
ternative splicing or of proteolytic cleavage of the full-length 
Figure 5. Sema4A reverse signaling regulates the activity of Rac1 and Cdc42. (a) MIA PaCa-2 cells stably expressing control shRNA or Sema4A shRNA 
either alone or together with shRNA-resistant wild-type (WT) or mutated (ΔC) Sema4A (as indicated) were starved and stimulated with or without 150 nM 
ecPlxnB1, and active Cdc42 was precipitated as described in Materials and methods. (b) T3M4 cells were treated with or without 150 nM ecPlxnB1, 
and Cdc42 activity was measured (pulldown). (c) Mature BMDCs generated from wild-type or Sema4A knockout mice (Sema4A KO) were stimulated with 
or without 150 nM ecPlxnB1 for 20 min. Cells were then lysed and the activity of Cdc42 was analyzed (pulldown). (d and e) MIA PaCa-2 cells stably 
expressing control or Sema4A shRNA were transfected with a FRET biosensor for Cdc42 and FRET ratios in response to 150 nM ecPlxnB1, and 100 µM of 
the Cdc42 inhibitor ML141 were analyzed as described in Materials and methods. (d) Representative traces are shown. CTRL, control. (e) The ecPlxnB1-in-
duced change of Cdc42 activity was calculated as a percentage of the difference between the FRET ratio at baseline (before treatments) and the FRET ratio 
after ML141 treatment. n = 12 for control shRNA, n = 8 for Sema4A shRNA. (f) ecPlxnB1 was applied to one side of a T3M4 cell through a micropipette 
(as outlined in white at the top of the images) as described in Materials and methods. Shown are representative images and the corresponding FRET 
ratios within two different areas of the cell over time. The regions of interest (ROIs) indicate regions proximal or distal to the site of ecPlxnB1 application, 
respectively. Bar, 10 µm. (g) MIA PaCa-2 cells were transfected with constructs encoding HA-Scrib, V5-Sema5A, and the GFP-tagged C-terminal portion 
of Scrib (GFP-Scrib amino acids 1224–1630) as indicated. Cells were stimulated with or without 150 nM ecPlxnB1. Proteins interacting with Sema4A 
were immunoprecipitated using V5 antibody and visualized using respective antibodies. IB, immunoblotting; IP, immunoprecipitation. Error bars represent 
means ± SD. *, P < 0.05.
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protein from the cell membrane (Tamagnone et al., 1999; Ar-
tigiani et al., 2003; Ito et al., 2014). Recently, increased lev-
els of a soluble, circulating Plexin-B1 portion were found in 
postmenopausal women with low bone mass (Anastasilakis et 
al., 2015); a secreted extracellular part of Plexin-B1 was also 
detected in proteomics studies (Farrah et al., 2011). Moreover, 
we detected soluble forms of Plexin-B1 of ∼70 kD in size re-
leased from lymphatic endothelial cells (HMV ECs). This form 
closely resembles an alternatively spliced, secreted form of 
Plexin-B1 (Tamagnone et al., 1999), suggesting a physiological 
relevance of secreted Plexin-B1.
Migration is the key feature of DCs during their life cycle 
(Randolph et al., 2008; Heuzé et al., 2013; Russo et al., 2013; 
Teijeira et al., 2014). To home to lymph nodes, peripheral DCs 
must migrate toward, and enter, lymphatic vessels. The inter-
action between DCs and the lymphatic endothelium can be 
Figure 6. Plexin-B1–Sema4A signaling induces internalization of Scrib. (a) T3M4 cells were incubated with or without 150 nM ecPlxnB1, and Scrib 
was visualized by immunostaining at the indicated time points after application of ecPlxnB1. Scrib localization was analyzed using ImageJ as described 
in Materials and methods. Time point 0 min: n = 41; 2.5 min: n = 61; 5 min: n = 54; 10 min: n = 53; 20 min: n = 26; 30 min: n = 45. (b) T3M4 cells 
stably transfected with control shRNA or with Sema4A shRNA alone or together with either shRNA-resistant wild-type Sema4A (S4A) or an shRNA-resistant 
Sema4A intracellular deletion mutant (S4AΔC) were incubated with 150 nM ecPlxnB1 for 30 min, and Scrib was visualized by immunostaining. Scrib 
localization was analyzed using ImageJ as described in Materials and methods. Bar graphs show mean values ± SD from at least 10 cells per condition. 
(c) Surface proteins of T3M4 cells transfected with control or Scrib were biotinylated. Cells were then incubated with or without 150 nM ecPlxnB1 for 
30 min, surface proteins were precipitated using streptavidin agarose, and bound Sema4A was visualized by Western blotting using an anti-Sema4A 
antibody (pulldown; right). Band intensities were quantified from six independent Western blots (left). ns, not significant. CTRL, control; IB, immunoblotting. 
Error bars represent means ± SD. *, P < 0.05; ***, P < 0.001.
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mediated by various molecules including ICAM1, JAM1, or 
CCR7 (Randolph et al., 2005), and it seems very likely that 
the complete set of molecules regulating the entry of DCs into 
lymphatic vessels is still to be determined. Our data strongly 
suggest that Plexin-B1 is a novel factor secreted by lymphatic 
endothelial cells, which regulates the migration of DCs into 
lymphatic vessels through Sema4A reverse signaling.
Using an unbiased approach to screen for Sema4A- 
interacting proteins, we identified Scrib as a binding part-
ner for Sema4A, which is critical for the promigratory effect 
of Plexin-B1. This is in line with the known function of Scrib 
in directed cell migration and wound healing in vitro and in 
vivo (Dow et al., 2007; Michaelis et al., 2013). Scrib interacts 
with the Cdc42/Rac1 GEF, βPIX, and this interaction positively 
regulates the GEF activity of βPIX (Audebert et al., 2004; Os-
mani et al., 2006; Goicoechea et al., 2014). We tested whether 
Plexin-B1, through its receptor Sema4A, may influence the 
Scrib–βPIX interaction and, in this way, affect the ability of 
βPIX to activate Cdc42 and Rac1. Indeed, we observed that in 
cells stimulated with Plexin-B1, the Scrib–βPIX interaction was 
impaired, thus providing a mechanistic basis for the Plexin-B1–
induced, Sema4A-mediated deactivation of Cdc42 and Rac1. 
Cdc42 and Rac1 are central regulators of cell migration, and 
numerous reports have shown that global inhibition of Cdc42 or 
Figure 7. Scrib and βPIX are required for Plexin-B1–Sema4A reverse signaling. (a) HEK293T cells transfected with V5-Sema4A, GFP-Scrib, and FLAG-βPIX 
were stimulated with or without 150 nM ecPlxnB1. Protein complexes were precipitated using anti-GFP antibodies and visualized with immunoblotting 
(IB). IP, immunoprecipitation. (b) MIA PaCa-2 cells were transfected with siRNAs as indicated, and cell migration in response to 150 nM ecPlxnB1 or 10% 
FBS in a transwell system was analyzed as described in Materials and methods (total n = 6 per condition). (c and d) THP1 cells were fully differentiated 
to DCs as described in Materials and methods. Cells were then stimulated with 150 nM ecPlxnB1 or 25 ng/ml CCL19 (as indicated), and Cdc42 activity 
(c) and cell migration (d) was analyzed by using a transwell system as described in Materials and methods (total n = 6 per condition). ns, not significant. 
CTRL, control. (e) MIA PaCa-2 cells were transfected with cDNAs encoding GFP or GFP-Scrib (amino acids 1224–1630), and cell migration in response 
to ecPlxnB1 was measured as described in Materials and methods. Shown are mean values ± SD from three independent experiments (total n = 8 per 
condition). Error bars represent means ± SD. **, P < 0.01; ***, P < 0.001.
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Rac1 activity in the cell—by expression of dominant-negative 
mutants, RNAi-mediated knockdown, or gene knockouts—in-
hibits cell migration (Ridley, 2015). It is therefore an intrigu-
ing finding of our study that the lowering of Cdc42 and Rac1 
activity by Plexin-B1–Sema4A signaling correlates with a 
promigratory effect toward higher Plexin-B1 concentrations. 
Importantly, directed cell migration requires a tight spatiotem-
poral coordination of Rho-GTPase activities (Raftopoulou and 
Hall, 2004). Although their activation is necessary to promote 
cell movement through the formation of filopodia and lamelli-
podia, they need to be rapidly deactivated to ensure fluent cell 
movement (Sadok and Marshall, 2014). Dynamic measure-
ments of small GTPase activity show that during cell migration, 
small GTPases are constantly activated and deactivated, rather 
than being active for the whole time (Žárský and Potocký, 2010; 
Gloerich and Bos, 2011; Kiyokawa et al., 2011; Tolias et al., 
2011; Lawson and Burridge, 2014; Zegers and Friedl, 2014). 
Using FRET assays, we visualized Cdc42 activity in cells with 
spatial and temporal resolution and observed that Cdc42 activ-
ity decreased at the site of Plexin-B1 application, indicating that 
in contrast to a global inhibition of Cdc42 activity, exposure 
to a gradient of Plexin-B1 translates into polarized modulation 
of Cdc42 activity. Another interesting observation of our FRET 
studies was the timeline of the inhibition of Cdc42 and Rac1 
activity by Plexin-B1. Although changes in Cdc42 or Rac1 ac-
tivity measured by FRET typically occur within seconds after 
the application of a stimulus (e.g., a chemokine or growth fac-
tor; Hanna et al., 2014; Martin et al., 2016), changes of Cdc42 
and Rac1 activity in response to Plexin-B1 were not detectable 
before 1.5–2 min. Our data therefore suggest that the promi-
gratory effect of Plexin-B1–Sema4A signaling results from a 
complex spatiotemporal regulation of Cdc42 and Rac1 activity.
Importantly, the function of Scrib critically depends on its 
localization at the plasma membrane. Mislocalization of Scrib 
promotes the invasion of cells through the extracellular matrix 
(Dow et al., 2007, 2008). We found that the interaction of Scrib 
with Sema4A upon Plexin-B1 binding promotes the internaliza-
tion of Scrib. Given that Scrib has several functions in addition to 
modulating Cdc42 and Rac1 activity through βPIX (Elsum et al., 
2012), this Plexin-B1–induced internalization of Scrib is likely 
to contribute to the effect on cell migration. Of note, our findings 
are consistent with previously published data, which show that 
the interaction between Scrib and CD74 results in the phosphor-
ylation of the C-terminal portion of Scrib and in the translocation 
of Scrib from the sites of cell-to-cell contacts at the plasma mem-
brane to the cytoplasm, thereby effectively enhancing cancer cell 
migration and invasiveness (Metodieva et al., 2013).
In summary, we demonstrate that Plexin-B1–Sema4A sig-
naling works bidirectionally. We have identified a novel signaling 
mechanism in which Sema4A serves as a receptor and mediates 
signals from its ligand Plexin-B1 to regulate migration and inva-
sion of cancer cells as well as chemotaxis of DCs. We propose a 
model in which the binding of Plexin-B1 to Sema4A promotes 
the interaction of Sema4A with Scrib, resulting in a destabili-
zation of the Scrib–βPIX complex and internalization of Scrib, 
thereby lowering the Cdc42/Rac1 GEF activity of βPIX and 
decreasing Cdc42 and Rac1 activity. The tight spatiotemporal 
integration of these events then controls directed cell migration. 
Reverse signaling might be a common feature of transmembrane 
semaphorins, turning the semaphorin–plexin system into a bidi-
rectional, rather than unidirectional, communication system be-
tween cells to regulate various biological processes.
Materials and methods
Cell culture and transfection
MDA-MB-231 and Calu-3 were purchased from ATCC; CaD2, A431, 
and SK-OV-3 were purchased from Cell Line Service. MIA PaCa-2, 
CFP AC, AsPc, and T3M4 were gifts from N.  Giese, and SHSY-5Y 
cells were provided by S. Rieken (University Hospital Heidelberg, Ber-
gheim, Germany). HeLa were provided by M. Bähr (German Cancer 
Research Center, Heidelberg, Germany). HMV EC-dLyAd cells and 
human umbilical vein endothelial cells were purchased from Lonza 
and cultured using the manufacturer’s instructions. MIA PaCa-2, A431, 
MDA-MB-231, Calu-3, SHSY-5Y, CFP AC, HeLa, and HEK293T cell 
lines were maintained in DMEM supplemented with 10% FBS. T3M4 
and AsPc cell lines were maintained in RPMI-1640 supplemented 
with 10% FBS. SK-OV-3 cells were maintained in McCoy’s 5a sup-
plemented with 10% FBS. THP1 cells were provided by B.  Strilic 
(Max Planck Institute for Heart and Lung Research, Bad Nauheim, 
Germany). Cells were maintained in RPMI-1640 supplemented with 
10% FBS and l-glutamine. To differentiate maturate THP1 cells into 
dendritic lineage cells, recombinant human IL-4 (100 ng/ml = 1,500 
IU/ml; AF-200-04; PeproTech) and granulocyte–macrophage colo-
ny-stimulating factor (GM-CSF; 100 ng/ml = 2,000 IU/ml; 315-03; Pe-
proTech) were added to the cell culture medium for 5 d. To maturate the 
DCs from THP1 cells, recombinant human TNF (20 ng/ml = 2,000 IU/
ml; 300-01A; PeproTech) and 200 ng/ml ionomycin (I24222; Thermo 
Fisher Scientific) were added to the cell culture medium. Cells were 
then incubated for 1–3 d in a humidified incubator and then used for 
experiments. siRNA transfections of THP1 were performed using the 
Amaxa Cell Line Nucleofector kit V (Lonza) before cell maturation. 
All cells were maintained at 37°C and 5% CO2. cDNA transfection 
in HEK293T cells was performed by the calcium phosphate method 
(Swiercz et al., 2002). Cells were transfected with cDNA by using Li-
pofectamine 2000 (Thermo Fisher Scientific) according to the manu-
facturer’s instructions. RNAiMAX reagent (Thermo Fisher Scientific) 
was used for the siRNA transfection.
Stably transfected MIA PaCa-2 and T3M4 cells were generated 
using lentiviruses according to the manufacturer’s protocols (Sig-
ma-Aldrich). Cells were selected in 1 µg/ml puromycin. For rescue 
experiments with Sema4A constructs, GFP-positive cells were sorted 
with a JSAN cell sorter (Bay Bioscience Co., Ltd.).
Antibodies and reagents
The following antibodies were purchased from commercial sources: 
anti-GFP (1: 2,000; ChromoTek), rabbit polyclonal anti-Sema4A 
(1:500; C1C3; GeneTex), anti-Scrib (1:1,000; 4475; Cell Signaling 
Technology), anti-RhoA (1:400; clone 67B9; Cell Signaling Tech-
nology), anti-RhoB (1:500; 2098S; Cell Signaling Technology), 
anti-RhoC (1:500; 3430S; Cell Signaling Technology), anti-Scrib 
(1:1,000; sc-28737; Santa Cruz Biotechnology, Inc.), mouse monoclo-
nal anti–α-tubulin (1:1,000; clone DM1A; Sigma-Aldrich), anti-HA 
(Roche), anti–HA-HRP (Sigma-Aldrich), anti–MYC-HRP (Sigma- 
Aldrich), anti–FLAG-HRP (Sigma-Aldrich), anti-Rac1 (1:500; 05–
389; clone 23A8; EMD Millipore), anti-V5 (1:1,000; AbD Serotec), 
anti-Cdc42 (1:1,000; BD), rat monoclonal anti–LYVE-1 (1:500; clone 
223322; R&D Systems), rabbit polyclonal anti-βPIX (1:400; 4515; 
Cell Signaling Technology), hamster monoclonal anti–CD11c-phy-
coerythrin (PE; 1:100; 12-0114-81; eBioscience), anti–B220-FITC 
(1:100; 553088; BD), anti–mouse T cell receptor (TCR)–PerCP/Cy5.5 
(1:100; clone H57-597; BioLegend), Fc-blocking antibody (1:100; 
clone 2.4G2; Bio X Cell), rabbit anti–goat Cy3 (1:200; Jackson Immu-
noResearch Laboratories, Inc.), goat polyclonal anti–Plexin-B1 (1:400; 
AF3749; R&D Systems), and anti-Sema4D (1:1,000; 610670; BD). 
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The rabbit polyclonal anti-Sema4A antibody 1–1-1-B1 was generated 
by ABmart against the peptide C-RTS ASD VDA DNN.GM-CSF and 
used at a 1:1,000 dilution. TNF (PeproTech) was used at concentrations 
of 20 ng/ml and 10 ng/ml. CCL19 (R&D Systems) was used at a final 
concentration of 25 ng/ml.
Plasmids and cloning
cDNA clones of human Sema4A were purchased from GE Health-
care. N-terminally V5-tagged full-length Sema4A and its deletion 
mutant Sema4AΔC (amino acids 1–707) were generated by PCR 
and subcloned into pcDNA3.1. A secreted Myc-His–tagged form of 
Plexin-B1 (ecPlxnB1; amino acids 20–534) in the pSecTag2 vector 
was described previously (Worzfeld et al., 2012). For lentivirus pro-
duction, V5-tagged Sema4A or Sema4AΔC was inserted into pLVX-
IRES-ZsGreen1 vector or pLVX-IRES-mCherry vector. pSPAX and 
pMD2G vectors were from Sigma-Aldrich. The intracellular parts 
of human Sema4A (amino acids 705–761), Sema4B (amino acids 
734–832), Sema4C (amino acids 685–833), Sema4D (amino acids 
756–862), Sema4F (amino acids 681–770), and Sema4G (amino 
acids 697–838) were cloned into pGEX4T-1 vector. Identities of all 
clones were confirmed by sequencing. HA-tagged Scrib and GFP-
tagged Scrib constructs were described previously (Audebert et al., 
2004). FLAG-tagged βPIX was described previously (Osmani et al., 
2006; Dacquin et al., 2011).
Mice
Sema4A knockout ES clones (ID: EPD0105_3_B05) were purchased 
from EUC OMM and microinjected into C57BL/6 blastocysts. To 
generate constitutive Sema4A knockout mice, mice carrying the Se-
ma4A “knockout-first” allele were crossed with E2a-Cre mice. The 
successful knockout of Sema4A was confirmed by Southern blotting. 
B6.Cg-Tg(Itgax-Venus)1Mnz/J expressing YFP under the CD11c 
promoter were purchased from The Jackson Laboratory. To generate 
mice lacking Sema4A and expressing YFP in CD11c-positive cells, Se-
ma4A knockout mice were crossed with mice expressing YFP under 
the control of the CD11c (Itgax) promotor. Plexin-B1 knockout mice 
were generated as described previously (Deng et al., 2007). Mice were 
maintained under specific pathogen-free conditions. All procedures 
involving animals were performed in accordance with German Ani-
mal Welfare legislation.
Complete list of siRNA/shRNA and primers used
siRNAs targeting human SEMA4A (SI04368567), SEMA4B 
(SI04283209), SEMA4C (SI04354056, SI04362197), SEMA4D 
(SI03053701, SI04952332), SEMA4F (SI04163019, SI04170726), 
SEMA4G (SI04188198, SI04230303), SNX27 (SI04209772, 
SI04220755), DLG1 (SI03046099, SI03102799), SYNJ2BP 
(SI04243848, SI04315535), RAN (SI04950505, SI04950512), FLNC 
(SI03648820, SI03648813), TLN1 (SI00301931, SI00086982), SCR 
IB (SI04182290, SI04295655), SORT1 (SI00729316, SI03115168), 
MAGI3 (SI02660448, SI02644439), ZRA NB1 (SI00118860, 
SI00118867), EIF2AK2 (SI02223011, SI02223018), MAGI1 
(SI04234328, SI03181080), JPH1 (SI04289887, SI04294829), PDL 
IM2 (SI00681625, SI04957029), KRT18 (SI02653658, SI03187996), 
PIGR (SI00040887, SI02629151), RAS SF5 (SI03056816, 
SI03058895), STMN1 (SI05389986, SI00301875), PRKD2 
(SI02224768, SI02224775), FMNL3 (SI04149607, SI04188884), 
SRP72 (SI04334981, SI04361308), and KIAA1817 (SI00460887, 
SI00460894) were purchased from QIA GEN. siRNA targeting human 
βPIX (SASI_Hs02_00325961, SASI_Hs02_00325962) was purchased 
from Sigma-Aldrich. A second independent Scrib siRNA was pur-
chased from QIA GEN (SI05053041).
shRNA targeting human Sema4A (TRCN0000058137) was from 
Sigma-Aldrich. The following RT-PCR primers were synthetized by 
Sigma-Aldrich: human SEMA4A (5′-GCT GCC CTT CAA CGT CAT-
3′, 5′-AGG TGA AGA CTG CGT AGA TGTG-3′), human SEMA4B (5′-
TGT GGC CTC AGC CTA CATT-3′, 5′-GAT CTT GTC ATC ATC GCC 
TTG-3′), human SEMA4C (5′-GAA GAA GGG CAC CAA CTT CA-3′, 
5′-TGG CTC CAT CAA GTC CTG TA-3′), human SEMA4D (5′-CTT 
CCT GAA AGC CCG ACTC-3′, 5′-GCA GCA CAT TGA AGA CCA AG-
3′), human SEMA4F (5′-TCC TGA AGA TGA GCG GTTG-3′, 5′-AGG 
AAG GGT GGT GAG AAT CC-3′), human SEMA4G (5′-AGT GCA 
GTG GGT GAT GAT GA-3′, 5′-TGA GTG AAG CTG CCA GAGC-3′), 
human GAP DH (5′-GCA TCC TGG GCT ACA CTGA-3′, 5′-CCA GCG 
TCA AAG GTG GAG-3′), human SCR IB (5′-CTC TGC CAC ATT CCT 
CACC-3′, 5′-GGG GTG GCA GTG GTT ATG-3′), and mouse SEMA4A 
(5′-ATG GAG TCT CCT GCG TGT TT-3′, 5′-GAA GCA GGT GGC AGT 
GATG-3′); (5′-CCC AGC CTG TTC TCA AGA CT-3′, 5′-ATA GAC GAC 
CTG GGT GGA TG-3′); (5′-GCA GCT GCC ATT CAA CATC-3′, 5′-CAC 
AGA CTG CTG AGC TCC TG-3′); (5′-AAC CCG GAG TGG GTA TGC-
3′, 5′-TTG GGG ACT GTC AGG ACT TC-3′).
RT-PCR
RNA was extracted using the RNeasy Mini kit (QIA GEN). cDNA was 
synthesized by reverse transcription (First Strand cDNA Synthesis kit; 
Roche). 60 ng cDNA per reaction was used. Primers were designed 
with the online tool provided by Roche. Quantitative PCR was per-
formed using the Light-Cycler 480 Probes Master system from Roche.
Protein purification
ecPlxnB1 (amino acids 20–534 of human Plexin-B1) was purified from 
conditioned medium of transiently transfected HEK293 cells (Worzfeld 
et al., 2012), whereas His-tagged Sema4D was produced from super-
natants of stably transfected CHO cells (Love et al., 2003) using met-
al-ion affinity chromatography (HisPUR Cobalt Resin; Thermo Fisher 
Scientific) followed by gel filtration chromatography (Superdex S200 
HR10/30; GE Healthcare). GST fusion proteins were expressed in 
Escherichia coli (DE3 Rosetta; EMD Millipore) and purified using 
Protino Agarose 4B (Macherey and Nagel; Swiercz et al., 2002).
Binding of ecPlxnB1 to Sema4A-expressing cells
MIA PaCa-2 cells were exposed to 150 nM ecPlxnB1 for 20 min, 
washed three times with PBS, and incubated with an anti–Myc-HRP 
antibody. After washing three times with PBS, HRP activity was mea-
sured using the General Elisa Protocol (Dako).
Proliferation assay
For proliferation assays, cells were seeded onto 6-well plates and 
counted using a Neubauer chamber on four consecutive days.
GST pulldown assay
3 × 107 cells (MIA PaCa-2, HEK293T, CaD2, or SK-OV-3 cell lines) 
were lysed in radioimmunoprecipitation assay (RIPA) lysis buffer 
(150 mM NaCl, 50 mM Tris, pH 7.4, 1% Triton X-100, 0.1% sodium 
dodecyl sulfate, 0.25% sodium deoxycholate, 1 µg/ml each of leupeptin, 
aprotinin, and pepstatin, and 1 mM 4-(2-aminoethyl)-benzosulfonylflu-
oridhydrochloride). GST fusion proteins (consisting of GST and the 
intracellular portions of different class 4 semaphorins) bound to Protino 
Agarose 4B were incubated with these lysates at 4°C for 2 h. Purified 
GST fusion proteins incubated with lysis buffer (without cells) and pu-
rified GST alone (lacking semaphorin intracellular portions) incubated 
with cell lysates or lysis buffer served as controls. Protino Agarose 4B 
beads were then washed three times in RIPA lysis buffer, and bound 
proteins were eluted by boiling with Laemmli buffer.
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Mass spectrometry analysis
Identification of proteins bound to the intracellular portions of class 4 
semaphorins (see previous paragraph) was performed in the Biomolec-
ular Mass Spectrometry Facility of the Max Planck Institute for Heart 
and Lung Research. Peptides were measured on an LTQ-Oribtrap XL 
instrument (Thermo Fisher Scientific). An Agilent 1200 (Agilent Tech-
nologies) was coupled via a nanoelectrospray ionization source to the 
mass spectrometer. A binary buffer system was used: (A) 0.5% ace-
tic acid in H2O and (B) 0.5% acetic acid in 80% acetonitrile. 15-cm 
in-house–packed columns were used for peptide separation along an 
increasing buffer B content concentration from 5 to 39% within 50 min 
followed by a washing step with 95% buffer B and a reequilibration to 
5% buffer B. The mass spectrometer operated in a Top5 method, and 
collision-induced dissociation fragmentation (normal collision energy: 
35) was used for peptide identification.
MaxQuant (version 1.2.0.18; Max Planck Institute of Biochem-
istry) and the implemented Andromeda search engine was used to cor-
relate measured mass spectrometry (MS)/MS spectra with the Homo 
sapiens or Mus musculus International Protein Index database. The 
false discovery rate on peptide and protein level was set to 1%, and the 
minimal peptide length was seven amino acids. MS and MS/MS mass 
tolerance were kept as default settings. N-terminal protein acetylation 
and oxidation at methionine residues were defined as variable modi-
fications, whereas carbamidomethylation at cysteine residues was set 
as a fixed modification. Ratios to identify possible binding partners of 
semaphorins were calculated based on the label-free quantification in-
tensity of protein groups.
Using a scoring system based on several parameters (label-free 
quantification intensity, number of identified peptides, number of iden-
tified unique peptides, and number of cell lines in which a potential 
interaction partner was identified), we identified a total of 65 potential 
interaction partners for class 4 semaphorins. Of those, we excluded 10 
proteins with known nuclear localization and function (e.g., histones), 
leaving 55 candidates. The 22 candidates with the highest score in the 
scoring system were further tested in migration assays using siRNAs 
directed against these candidates (see next section).
Migration and invasion assays
For transwell migration assays, 5 × 104 cells were serum starved 
overnight and seeded into 96-transwell migration plates (order MAM 
IC8S10; EMD Millipore). Control buffer or buffer containing 150 nM 
ecPlxnB1 was added to the lower chamber of the respective wells. 18 h 
later, nonmigrated cells on the upper surface of the filter were removed, 
and migrated cells on the lower surface of the filter were fixed in meth-
anol and stained with toluidine blue. Cell migration was analyzed by 
measuring the staining intensity using ImageJ (National Institutes of 
Health; labeling of y axis in the respective experiments with “cell mi-
gration”) or by counting the number of migrated cells manually (label-
ing of y axis in the respective experiments with “number of migrated 
cells”). For transwell migration assays of THP1 cells, cells were al-
lowed to migrate for 3 h, and cells in the lower chamber were counted.
For 3D migration assays of DCs, 107 cells/ml mature BMDCs, 
107 cells/ml CD11c+ splenic DCs (purity > 80%), or 107 cells/ml THP1 
cells were mixed with a collagen I gel and put into µ-Slide Chemotax-
is3D migration chambers (ibidi). 150 nM ecPlxnB1 was added to one of 
the reservoirs, and cell migration was imaged by live-cell imaging over 
a period of 2–4 h by capturing images every 1–2 min (see Microscope 
image acquisition). Cells were tracked using the Manual Tracking 
Plug-in (Fiji) of ImageJ. For every 3D migration experiment, the tracks 
of 10–37 cells were monitored. The y-forward migration index (FMIy) 
and center of mass were calculated using the Chemotaxis and Migra-
tion tool plugin (ibidi) for ImageJ. The FMIy represents the efficiency 
of the forward migration of cells in relation to the y axis, and the center 
of mass represents the averaged point of all cell endpoints (ibidi).
Invasion assays were performed as described previously 
(Worzfeld et al., 2012).
DC isolation, culture, and transfection
For the isolation of splenic DCs, spleens from C57BL/6 mice were di-
gested by collagenase D and passed through a 40-µm nylon mesh to 
remove debris. Erythrocytes were lysed and cells were washed three 
times with RPMI-1640 medium. CD11c+ DCs were FACS sorted with 
CD11c-PE antibody. For the generation of BMDCs, bone marrow was 
flushed from C57BL/6 mice femurs and tibias with ice-cold RPMI-1640 
medium. Erythrocytes were lysed and cells were passed through a 40-µm 
nylon mesh to remove debris. Cells were washed three times with RPMI-
1640 medium and put into 100-mm Petri dishes in complete growth me-
dium plus 20 ng/ml GM-CSF (Inaba et al., 1992). Medium was changed 
every 2 or 3 d, and DCs were collected from days 6 to 8.  10 ng/ml 
TNF was added overnight to DCs for maturation. BMDCs were trans-
fected using lentiviruses carrying V5-tagged Sema4A-IRES-mCherry or 
V5-tagged Sema4AΔC-IRES-ZsGreen1. In brief, HEK293 cells were 
transiently transfected with vectors for generating lentiviruses. 3 d after 
transfection, the virus-containing medium was collected and filtered. 
10 µg/ml hexadimethrine bromide (Polybrene) and 20 mM Hepes were 
added to viruses. BMDCs were prepared as described in this paragraph 
and seeded onto 24-well plates. The next day (day 2), virus-containing 
medium was added, and the plates were centrifuged at 2,500 rpm at 
30°C for 90 min. The plates were incubated at 37°C and 5% CO2 for 
3 h followed by centrifugation at 1,500 rpm for 5 min. Supernatant was 
removed and fresh culture medium was added to the cells. The procedure 
was repeated two more times (on days 3 and 4; Dudziak et al., 2007).
FACS sorting
MIA PaCa-2 and T3M4 cells infected with pLVX-IRES-ZsGreen1- 
Sema4A or pLVX-IRES-ZsGreen1-Sema4AΔC lentiviruses were tryp-
sinized, and cells were resuspended in PBS containing 0.5% BSA and 
1 mM EDTA. GFP-positive cells were sorted using a JSAN cell sorter. 
Splenic DCs were labeled and sorted with CD11c-PE. Purity was deter-
mined using FACS Canto II (BD) by labeling the cells with CD11c-PE, 
B220-FITC, and TCR-Cy5.5.
Ex vivo crawl-in assay
The ex vivo crawl-in assay was adapted from Weber and Sixt (2013). 
C57BL/6 mice were sacrificed, their ears removed, and ears were sepa-
rated into dorsal and ventral sheets. Ventral ear sheets without cartilage 
were immunostained and mounted on self-made migration chambers 
with the dermal surface exposed on top. DCs were labeled with 1.25 
µm seminaphtharhodafluor (Thermo Fisher Scientific) or 1.25 µm 
carboxyfluorescein succinimidyl ester (Thermo Fisher Scientific) in 
culture medium and added on top of the dermis. After 5–10 min of 
incubation at 37°C and 5% CO2, noninfiltrated DCs were removed, and 
new medium was added on top of the dermis. Ear sheets were incubated 
in a climatized (37°C, 5% CO2) chamber for different time periods, 
washed with PBS, fixed in 1% PFA, and mounted for confocal mi-
croscopy using Fluoromount W (Serva Electrophoresis). Alternatively, 
migration of DCs was recorded by live-cell imaging.
Immunoprecipitations and Cdc42/Rac1 pulldown assays
For protein immunoprecipitation, cells were lysed in ice-cold RIPA 
buffer (150 mM NaCl, 50 mM Tris, pH 7.4, 1% Triton X-100, 0.1% 
sodium dodecyl sulfate, 0.25% sodium deoxycholate, 1 µg/ml each 
of leupeptin, aprotinin, and pepstatin, 1  mM 4-(2-aminoethyl)-ben-
zosulfonylfluoridhydrochloride, and 1  mM Na3VO4). Lysates were 
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centrifuged, and supernatants were incubated with different antibodies 
in the presence of Protein A/G PLUS Agarose (Santa Cruz Biotechnol-
ogy, Inc.). Agarose beads were then centrifuged and washed several 
times using ice-cold RIPA buffer. Finally, antibody-bound proteins 
were eluted by boiling the beads in Laemmli buffer. Samples were then 
subjected to Western blotting.
Activities of Rac1 and Cdc42 were measured using GST-tagged 
PAK1 (Swiercz et al., 2002). The activities of RhoA, RhoB, and RhoC 
were tested using GST-tagged Rhotekin (Ren and Schwartz, 2000).
Western blot
Western blotting was performed according to standard laboratory 
protocols. In brief, cell lysates or precipitates were separated using 
SDS-PAGE, followed by transfer onto nitrocellulose membranes 
and blocking of nonspecific binding sites with 5% nonfat milk in 
Tris-buffered saline with Tween 20 (TBST) for 1 h at room tempera-
ture. The blots were probed with primary antibodies at 4°C overnight, 
washed three times with TBST, incubated with secondary antibodies 
for 1.5  h at room temperature, and washed again three times with 
TBST, and proteins were visualized using an ECL system (Thermo 
Fisher Scientific). Western blot band intensities were quantified using 
the Gel Analysis tool of ImageJ.
Cell surface biotinylation and precipitation of biotinylated proteins
Cell surface biotinylation was performed using the EZ-Link 
Sulfo-NHS-Biotinylation kit (Thermo Fisher Scientific) according to 
the manufacturer’s instructions. Biotinylated cells were lysed in ice-
cold RIPA buffer (Fig. S1 f) or a buffer containing 25 mM Tris-HCl, 
pH 7.4, 150 mM NaCl, 5 mM EDTA, and 1% Triton X-100 (Fig. 6 c), 
and biotinylated surface proteins were precipitated from the clarified 
lysates using streptavidin agarose (Thermo Fisher Scientific).
Immunostaining and imaging
Cells were starved overnight and stimulated with 150 nM Plexin-B1. 
Cells were then fixed with 4% PFA and stained using an anti-Scrib 
(1:300; sc-28737) and an Alexa Fluor 594–conjugated secondary anti-
body. Images were acquired using an SP5 confocal microscope (Leica 
Biosystems). Membrane staining versus total staining was analyzed 
using the Profile Plot function of ImageJ.
Microarray analysis
Expression data from lymphatic endothelial cells were analyzed based 
on Affymetrix Mouse Genome 430 2.0 arrays, downloaded from GEO 
(dataset GSE22034; four replicates). The array signals were aggregated 
and normalized via robust multiarray average, including quantile nor-
malization, and were used to calculate the frequency distribution of 
gene expressions. In total, 45,101 single gene expression values were 
used. To generate one single representative value for each gene, the 
mean of all replicates was calculated. The resulting values were used 
for frequency calculation. Bin size was set to 0.5.
FRET measurements
Plasmids encoding Cdc42 (pTriEx4-Cdc42-2G) and Rac1 (pTriEx4-
Rac1-2G) FRET biosensors were a gift from O. Pertz (University of 
Bern, Bern, Switzerland; plasmids 66110 and 68814, respectively; 
Addgene; Fritz et al., 2015). MIA PaCa-2 or T3M4 cells were trans-
fected with plasmids encoding a FRET biosensor and MeGAP (=SRG 
AP3) and seeded on glass coverslips. For FRET measurements, cells 
were incubated in FRET buffer (137 mM NaCl, 5.4 mM KCl, 2 mM 
CaCl2, 1 mM MgCl2, and 10 mM Hepes, pH 7.3). FRET imaging was 
performed on an inverted fluorescence microscope (Eclipse Ti; Nikon) 
as described previously (Wolters et al., 2015) using a light-emitting 
diode excitation system (pE-2; CoolLED) containing light-emitting di-
odes emitting light at 425 nm and 500 nm, respectively. Dual emission 
(cyan and yellow) images with an exposure time of 2 ms were acquired 
with a rate of 12/min. Ratio images (F535/F480) were calculated with-
out correction for bleedthrough and false excitation. Cells that were 
not responsive to the Cdc42 inhibitor, ML141, or to the Rac inhibitor, 
EHT1864, were excluded from the analysis.
Experiments designed to measure the effects of a local Plexin-B1 
stimulus were performed by placing a micropipette on one side of the 
cell while the cell was exposed to a continuous laminar flow of FRET 
buffer from the opposite direction that was applied using a perfusion 
system (ALA-VC3-8SP; ALA Scientific Instruments). Images were 
acquired every 5 s with illumination times of 40–60 ms. Because FRET 
was measured with a monomolecular sensor, no background subtrac-
tion and bleedthrough corrections were performed. The images were 
generated using NIS Elements (Nikon) and show averages of four con-
secutive data points to reduce noise.
Microscope image acquisition
Live-cell imaging of DC migration in vitro was performed with an 
inverse microscope (37°C, 5% CO2, 10× objective; IX-1; Olympus). 
Confocal laser-scanning microscopes used in this study were Leica 
Biosystems SP5 (40× and 63× objectives) and Leica Biosystems SP8 
(for live-cell imaging; 37°C, 5% CO2, 20× objective). Analysis of live-
cell imaging of DC migration ex vivo was done by Imaris software.
Statistical analysis
Statistical significance was evaluated by Student’s t test. Data shown in 
Figs. 1 (b–f), 2 (a–d), 3 (a and b), 4 (b), 5 (d), 6 (a–c), 7 (b, d, and e), 
S1 (a, g, h, j, and k), S2 (b, d, and e), S3 (a), S4 (b, d, and f), and S5 (a 
and g) are means ± SD. Data shown in Fig. 3 (d–f) are means ± SEM. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
Online supplemental material
Fig. S1 provides additional evidence that the extracellular portion of 
Plexin-B1 increases cancer cell migration through Sema4A. Fig. S2 
shows the purity of FACS-sorted splenic DCs, the generation and vali-
dation of Sema4A-deficient mice, and the migration parameters of DCs 
in response to different stimuli. Fig. S3 depicts additional analyses of 
BMDC migration toward ear lymphatic vessels and provides an expres-
sion analysis of lymphatic endothelial cells and BMDCs. Fig. S4 shows 
that the promigratory effect of the extracellular portion of Plexin-B1 
depends on Scrib. Fig. S5 demonstrates the modulation of Rho-GTPase 
activities by the extracellular portion of Plexin-B1 through Sema4A–
Scrib. Video 1 shows the migration of wild-type and Sema4A-deficient 
BMDCs toward ear lymphatic vessels ex vivo.
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